Emflaza
Deflazacort
Emflaza je kortikosteroid určený k léčbě svalové dystrofie Duchenneova typu (DMD) u pacientů ve věku od 5 let.
more
| Balení | Pomocí pilulku | Cena | Úspora | Objednat |
|---|---|---|---|---|
|
120 tablet
Letecká doprava zdarma
Hot
|
Kč 110.82
|
Kč 13298.95Kč 110.82
|
Kč 2413.37
|
|
|
90 tablet
Letecká doprava zdarma
Hot
|
Kč 116.87
|
Kč 10518.00Kč 116.87
|
Kč 1266.24
|
|
|
60 tablet
Letecká doprava zdarma
Hot
|
Kč 120.89
|
Kč 7253.42Kč 120.89
|
Kč 602.74
|
|
|
36 tablet
Letecká doprava zdarma
Hot
|
Kč 127.59
|
Kč 4593.39Kč 127.59
|
Kč 120.31
|
|
|
24 tablet
|
Kč 130.94
|
Kč 3142.46Kč 130.94
|
|
| Balení | Pomocí pilulku | Cena | Úspora | Objednat |
|---|---|---|---|---|
|
90 tablet
Letecká doprava zdarma
Hot
|
Kč 134.33
|
Kč 12089.84Kč 134.33
|
Kč 2414.88
|
|
|
60 tablet
Letecká doprava zdarma
Hot
|
Kč 145.07
|
Kč 8704.35Kč 145.07
|
Kč 965.47
|
|
|
36 tablet
Letecká doprava zdarma
Hot
|
Kč 154.46
|
Kč 5560.67Kč 154.46
|
Kč 241.22
|
|
|
24 tablet
Letecká doprava zdarma
Hot
|
Kč 161.16
|
Kč 3867.93Kč 161.16
|
|
Deflazacort tablets
What is this medicine?
Deflazacort a corticosteroid indicated for the treatment of Duchenne muscular dystrophy (DMD) in patients 5 years of age and older.
What should I tell my health care providers before I take this medicine?
They need to know if you have any of these conditions:
- Hypersensitivity to deflazacort;
- Alterations in Endocrine Function: Hypothalamic-pituitary-adrenal axis suppression, Cushing’s syndrome, and hyperglycemia;
- Immunosuppression and Increased Risk of Infection: Increased risk of new, exacerbation, dissemination, or reactivation of latent infections, which can be severe and at times fatal;
- Alterations in Cardiovascular/Renal Function: elevated blood pressure and sodium, and for decreased potassium level;
- Gastrointestinal Perforation: GI disorders;
- Behavioral and Mood Disturbances: euphoria, insomnia, mood swings, personality changes, severe depression, and psychosis;
- Effects on Bones: decreases in bone mineral density;
- Serious Skin Rashes;
- Ophthalmic Effects: May include cataracts, infections, and glaucoma;
- Vaccination: Do not administer live or live attenuated vaccines to patients receiving immunosuppressive doses of corticosteroids.
How should I use this medicine?
The recommended once-daily dosage is approximately 0.9 mg/kg/day administered orally. Discontinue gradually when administered for more than a few day..
What may interact with this medicine?
- Moderate or strong CYP3A4 inhibitors: Give one third of the recommended dosage;
- Avoid use of moderate or strong CYP3A4 inducers, as they may reduce efficacy.
What side effects may I notice from this medicine?
The most common adverse reactions are Cushingoid appearance, weight increased, increased appetite, upper respiratory tract infection, cough, pollakiuria, hirsutism, central obesity, and nasopharyngitis.
